FDA Inspection 1102691 - Boehringer Ingelheim Pharma Gmbh & Co Kg - September 19, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Boehringer Ingelheim Pharma Gmbh & Co Kg

Record Details

This FDA Inspection record concerns Boehringer Ingelheim Pharma Gmbh & Co Kg, with an inspection on September 19, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Boehringer Ingelheim Pharma Gmbh & Co Kg
Inspection Date: September 19, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · db6a02f0-3ebc-4c6a-b689-a50299bdaa08

Violation Codes3

21 CFR 211.100(b)21 CFR 211.113(b)21 CFR 211.192

Full citation text and observation details available on the Dashboard.